Strumento inattivo

Azioni Trivascular Technologies Inc

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

TriVascular Technologies, Inc. Reports Third Quarter Financial Results	09/11/15
Preliminary Results of the LIFE Study Presented at VIVA 2015	03/11/15
Four-Year Results From Global Ovation Pivotal Trial Presented at VIVA 2015	03/11/15
Trivascular Technologies : Brower Piven Commences An Investigation Into The Proposed Sale Of TriVascular Technologies, Inc. And Encourages Investors To Contact The Firm For Additional Information	29/10/15
TRIVASCULAR TECHNOLOGIES : Former SEC Attorney Willie Briscoe and Powers Taylor LLP Believe the Acquisition by Endologix, Inc. May be Unfair to Shareholders	28/10/15

Dirigenti	Titolo	Età	Da
John Onopchenko CEO	Chief Executive Officer	66	-
Vaseem Mahboob DFI	Director of Finance/CFO	55	03/02/16

Settore

	Variaz. 1 gen.	Capi.
STRYKER CORPORATION	+12,37%	129 Mrd
SMITH & NEPHEW PLC	-9,23%	10,77 Mrd
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+2,17%	9,05 Mrd
INSPIRE MEDICAL SYSTEMS, INC.	+18,79%	7,38 Mrd
GLAUKOS CORPORATION	+20,77%	4,88 Mrd
AXONICS, INC.	+6,97%	3,41 Mrd
ENOVIS CORPORATION	-1,41%	3,07 Mrd
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-5,07%	2,24 Mrd
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-4,22%	2,12 Mrd